Best stocks of Q3 2026 (final results)

The quarter's leaders by return since July 1 · Final standings

From the July 1, 2026 close to the September 30, 2026 close, Moderna (MRNA) gained +165.61%, the best Q3 2026 run in the S&P 500. Q3 is in the books: these are the quarter's final standings.

Rank	Company	Ticker	Price	Q3 return
1	Moderna	MRNA	$241.46	+165.61%
2	Everpure	P	$93.44	+69.54%
3	Veeva Systems	VEEV	$310.10	+54.95%
4	Marathon Petroleum	MPC	$377.32	+49.70%
5	Okta, Inc.	OKTA	$171.16	+48.88%
6	Illumina, Inc.	ILMN	$208.00	+48.83%
7	Palantir Technologies	PLTR	$154.99	+48.77%
8	Supermicro	SMCI	$27.08	+48.54%
9	Phillips 66	PSX	$247.04	+47.08%
10	Workday, Inc.	WDAY	$200.17	+46.20%
11	Hewlett Packard Enterprise	HPE	$44.16	+45.73%
12	Valero Energy	VLO	$351.23	+44.42%
13	HP Inc.	HPQ	$29.44	+43.42%
14	Accenture	ACN	$265.16	+41.52%
15	Salesforce	CRM	$222.41	+40.89%
16	Cognizant	CTSH	$66.54	+40.68%
17	Twilio	TWLO	$200.96	+39.75%
18	Gartner	IT	$198.07	+39.46%
19	Zebra Technologies	ZBRA	$321.64	+39.37%
20	CrowdStrike	CRWD	$217.20	+37.05%
21	Revvity	RVTY	$150.83	+35.57%
22	NetApp	NTAP	$169.38	+34.75%
23	Microsoft	MSFT	$535.93	+33.72%
24	IQVIA	IQV	$264.88	+32.31%
25	Thermo Fisher Scientific	TMO	$676.94	+31.60%

New in 2026

No new-in-2026 S&P 500 additions with price history yet. The 2026 S&P 500 additions (FDXF and HONA, both 2026 spin-offs) have no December 31, 2025 price, so they cannot be measured on a genuine year-to-date basis, and are excluded rather than ranked on invented data. When a 2026 addition with a full price history appears, it will be listed here.

Q3 2026 return measured from the July 1, 2026 close to the September 30, 2026 close across 500 S&P 500 constituents with usable Q3 price data. Stocks without a genuine pre-/on-July-1 price (e.g. 2026 spin-offs) are excluded; prices adjusted for splits and dividends. Source: Yahoo Finance.

← Full S&P 500 YTD leaderboard

For informational purposes only, not financial advice.

About · Contact · Privacy Policy · Affiliate Disclosure · Methodology